View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
AstraZeneca has received approval to update the patient instructions on its Pulmicort Flexhaler (budesonide inhalation powder), thanks to nurses' reports on patient confusion with the device's dose counter.
The number in the device's dose-counter window doesn't visibly move with each administered dose. Patients will see that the counter has advanced only after receiving about five doses. Because patients didn't see the dose counter moving, many thought they weren't getting any medication with the first actuation of the inhaler, leading them to take extra doses. The new patient instructions in the product labeling provide more detailed information about how the dose counter works.
If you're caring for a patient who uses this inhaler, teach him how the dose counter works and have him demonstrate using it. An updated patient-information leaflet is available at http://www.pulmicortflexhaler.com/assets/PatientInstructions.pdf.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top